FDA May Revoke Approval of Avastin for Breast Cancer Marking the Start of ‘Death Panel’ Drug Rationing


US regulators will delay consideration of the colon-cancer drug Avastin as a treatment for breast. cancer

America’s health watchdog is considering revoking its approval of the drug Avastin for use on women with advanced breast cancer, leading to accusations that it will mark the start of ‘death panel’ drug rationing.  A decision to rescind endorsement of the drug would reignite the highly charged debate over US health care reform and how much the state should spend on new and expensive treatments.